Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5234_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
334 Index
Dopamine, 7, 8, 11, 91, 193, 194, 269, 272, 311 Dopaminergic, 7, 90, 241 Drug, 11, 12, 13, 22, 23, 25, 26, 29, 93, 94, 95,
Drug administration, 90, 92 Drug delivery, 90, 92, 93, 94, 95, 96, 97, 98, 99,
96, 97, 98, 99, 100, 102, 103, 197, 241,
244, 257
100, 102 , 103
E
Electroencephalography (EEG), 9,
Electromyography, 10, 201, 270 En erg y, 9, 27, 35, 37, 148 , 150, 153, 154, 155,
Environment, 19,
Epilepsy, 3, 5, 7, 8, 9, 10, 11, 12, 14, 18, 23, 29,
Exoskeleton, 314
34, 316
156, 159
75, 76, 97, 98, 101, 113, 128,
294, 295, 307
38, 39, 81, 84, 91, 95, 98, 100, 101, 112 , 204, 286
F
F1 score, 114, 119, 120, 176 , 207, 208, 209, 210,
Factor analysis, 262, 263 Feature extraction, 85, 86, 87, 114, 133, 14 8, 153,
Feature map, 115, 116, 117, 179, 180 , 181, 245,
Feature selection, 148, 162, 175, 17 7, 197, 199,
Filter methods, 205, 206 FMRI, 9, 22, 33, 34, 38, 72, 75, 82, 86–87, 123, 143,
Formulations, 26, 98, 153 Frequency domain feature, 149
271, 275, 276, 279, 286, 287, 291, 292, 301, 302, 307
159, 162, 166 , 176 204, 225, 243, 248, 262, 274, 297, 316
274, 299
203, 205, 206, 231, 270
174, 203, 204, 227, 243, 252, 291, 312
, 177, 199, 202, 203,
G
Gait analysis, 149, 150, 313, 314 Gene therapy, 11, 12, 14, 100, 102, Generative Adversarial Networks (GANs), 82,
124, 125, 126, 127, 128, 129, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142 , 143, 14 4, 231, 244, 251
Genetic disorders, 6, 10 0 Gradient motion nulling (GMN),
72, 73
Grey wolf optimizer, 297, 299, 300 Guillain-Barré syndrome, 7, 8
103
H
Healthcare, 23, 25, 26, 42, 45, 46, 47, 48, 49, 50,
Healthcare professionals, 49, 60, 61, 172 , 208,
Hemorrhage, 239 Huntington’s disease, 6, 7, 8, 10, 12, 10 0, 101,
Hyperparameter tuning, 175, 276
51, 52, 54, 55, 56, 59, 60, 61, 83, 86, 87, 101, 137, 141, 142, 14 4, 172 , 195, 196, 198, 208, 210, 213 219, 223, 232, 242, 258, 267
270, 292
286
, 214, 215, 216,
I
ICMR, 45, 46 Image registration, 2 51, 253 Image segmentation, 21, 143, 244, 252 Implants, 23, 39, 99, 103 Inammation, 6, 13, 91, 93
K
KNN, 222, 226, 227, 250, 259, 260, 263, 264,
265, 266, 267, 270, 271, 291, 314
L
Ligands, 96, 97, 102 Linear Discriminant Analysis (LDA),
Liposomes, 97, 98 Logistic regression,
Long Short Term Memory (LSTM), 110, 11 5,
Loss function, 28, 132, 170, 171, 276, 296
205, 206
114, 199, 207, 210, 222, 271,
287, 314
118, 120, 122, 176, 243, 244, 271
M
Machine learning, 11, 12, 20, 21, 37, 48, 49, 50,
Magnetic Resonance Imaging (MRI), 3, 34, 48,
Magnetoencephalography (MEG), 9, 34, 243 Mean Absolute Error (MAE), 209, 210 Mel-Frequency Cepstral Coefcients (MFCC),
Migraine, 7, 8, 12, 91, 112, 128 Mild Cognitive Impairment (MCI), 176, 223,
Mildly demented, 239, 240, 241 Mish activation function, 178, 179, 188
51, 55, 75, 83, 101, 109, 114, 122, 123, 220, 239, 312
49, 51, 69, 81, 90, 126, 149, 161, 168, 174, 196, 219, 239, 269, 291
148
226, 229, 243, 291, 296
Index 335
MLP (multilayer perceptron), 249, 250, 314 Model communication cost, 302, 304, 307 Monoclonal antibodies, 12, 95 Motion insensitive sequences, 73 MSE, 127, 128, 209, 210 Multiclass classication, 174, 175 , 291 Muscular dystrophy, 6, 7, 101 Mutations, 6, 7, 8, 100, 101, 103
N
Nanoparticles, 93, 96, 97, 98, 102 Nerves, 3, 8, 10, 98, 109, 111, 112 , 193, 243 Neural networks, 22, 28, 33, 37, 36, 39, 40, 41,
Neurocomputing, 19 Neurodisease, 22, 60, 243, 290 Neuroimaging, 9, 10, 14, 20, 21, 22, 26, 31, 33,
Neuroinformatics, 19, 21, 22, 38 Neurological disorders, 3, 5, 69, 77, 81, 83, 86,
Neurological procedures, 45 Neuropathy, 7, 8, 10 Neuropharmacology, 12 Neurorehabilitation, 26, 311 Neurotransmitters, 91 Noise reduction, 71, 72, 78, 133, 153, 163, 248,
Normalization, 115,
72, 82, 114 , 148, 149, 159, 162, 163, 166 , 171, 176, 197, 198, 199, 206, 207, 210, 211,
299, 294, 307, 313, 316
34, 40, 41, 57, 58, 73, 75, 81, 82, 83, 84, 85, 86, 87, 88, 90, 103, 124, 125, 126, 127, 128, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142 , 143, 144 , 174, 175, 197, 200, 202, 203, 207, 212, 219, 220, 223, 226, 239
90, 91, 92, 93, 94, 96, 98, 100, 101, 109, 111, 113 , 114, 115, 117, 119, 121, 122, 123, 138, 139, 141, 142, 143, 14 4, 191, 239, 242, 254, 286
251, 253
180 , 182, 202, 252, 253, 299
220, 231, 232, 242, 243, 244,
204,
118, 153, 163, 164 , 168, 176 ,
Permeability, 90, 94, 95, 97 Personalized medicine, 14, 19, 23, 25, 26, 83,
Pervasive stigma, 242 Physical restraints, 74 Positron emission tomography, 9, 126, 174, 203,
Precision, 9, 25, 26, 32, 34, 41, 57, 58, 59, 84, 86,
Pretrained models, 176 , 244, 269, 270, 271, 272,
Principal Component Analysis (PCA), 197, 199,
Probabilistic neural network (PNN), 243, 248,
Probability, 27, 129, 130, 154, 171, 222, 226, 247,
Prognosis, 26, 86, 90, 142, 161, 200, 328 Proprioception, 322, 323, 324, 325, 326,
Prospective motion correction (PMC), 74
85, 90, 103, 143, 195, 211,
267
258,
219, 239, 292
87, 97, 99, 102, 114, 119, 120, 132,
133, 139, 148, 149, 150, 163, 175, 176,
196, 205, 207, 208, 209, 210, 213, 214,
254, 286, 287, 292, 293, 301, 312,
326, 328
275, 286, 287, 293
202, 205, 206,
228, 229, 231
249
248, 260
327, 328
220, 223, 224, 226,
R
Random forest, 114, 149, 177, 206, 210, 211, 221,
Recall, 207, 208, 209, 210 Receptors, 96, 97, 324 Recurrent neural network, 110 , 115, 117, 118, 120,
Regression, 114 , 181, 197, 198 Resnet, 110 , 115, 118, 120, 122, 177, 178, 17 9,
Risk, 91 RMSE, 209, 210 Robotic rehabilitation, 312, 314
270, 271, 292, 311, 313, 314
122, 245, 313
, 243, 244, 250
188, 251, 301, 302, 304, 305
O
Oasis dataset, 182, 183, 188 , 292 Omega-3 fatty acids, 13
P
Parkinson’s disease, 3, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 18, 23, 24, 55, 56, 90, 91, 193, 197,
211, 239, 257, 269, 271, 311, 312, 314 ,
315, 316
Pathogenesis, 90 Performance indices, 156
S
Sampler, 180, 181 Scapular dysfunction, 323 Schizophrenia, 32, 95, 239, 241, 242,
243, 254, 286
Sclerosis, 90, 257 Segmentation, 251, 252 Segnet, 291 Seizure disorders, 5 Sensorimotor, 39, 149, 324, 325, 328 Serotonin, 91 Signal processing, 28, 148
336 Index
Slice timing, 252 Smoking, 91, 92 Smoothing, 253, 254 Sparse coding, 133 Spatial transformer network, 174 , 178, 179, 180 ,
181, 182 , 184, 18 5, 186, 18 8
Speech biomarkers, 311 Statistical evaluation, 153 Stroke, 3, 4, 7, 8, 9, 11, 12, 13, 23, 38, 56, 82, 85,
87, 90, 91, 101
Stylegan, 131 Summation layers, 249 Supervised learning, 197, 198, 199, 206, 207,
209, 210, 211, 213, 215, 219, 220, 221,
222, 223, 224, 227, 231, 232, 257, 258,
259, 261, 267, 311
T
Targeted drug delivery, 90, 93, 95, 98,
99, 103
Time domain feature, 150 Tourette syndrome, 4 Transformer network, 188 Transient ischemic attacks, 7 Transporters, 94, 95, 96 Tu mor s, 92, 98, 99, 102
U
U-net, 133 Ultrasound, 94, 97 Unied Parkinson’s Disease Rating Scale
(UPDRS), 315
Unsupervised learning, 39, 133, 206, 219, 220,
221, 222, 223, 224, 228, 229, 231, 232
V
Variational encoders, 133 Vec tors, 93, 100 Virtual health assistants, 45, 50 Virtual reality, 312, 314 , 315 Visual geometry group-16 (VGG-16), 110, 114,
115, 118, 120, 122
W
Wasserstein GANs (WGAN), 131 Wavelet transform, 28, 71, 75, 199, 204 Wrapper methods, 205, 206
Z
Zolgensma, 11, 12, 102